Filing Flows › Stemtech (STEK) › Q2 2026 › vs Q2 2025
Stemtech (STEK) Q2 2026 vs Q2 2025 (year over year)
Stemtech's revenue fell $69K (-10%) from $698K in Q2 2025 to $629K in Q2 2026.
Stemtech, Q2 2026: revenue $629K (-10% year over year), operating margin -20.0%, net loss $292K, operating cash flow −$55K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $629K | $698K | −$69K | -10% |
| Net loss | $292K | $296K | −$4K | -1% |
| Costs & expenses | $922K | $999K | −$77K | -8% |
| Operating costs | $755K | $999K | −$244K | -24% |
| Interest & other, net | $167K | −$5K | $171K | — |
| Cost of revenue | $164K | $146K | $18K | +12% |
| General & admin | $540K | $698K | −$158K | -23% |
| Other operating costs | $52K | $155K | −$103K | -67% |
| Operating cash sources | $292K | $296K | −$4K | -1% |
| Depreciation & amortization | $42K | $42K | −$4 | 0% |
| Share-based compensation | $109K | $109K | $1 | 0% |
| Working capital & other | $86K | $220K | −$134K | -61% |
| Cash used in operations | $55K | −$75K | $130K | — |
| Net loss absorbed | $292K | $296K | −$4K | -1% |
Questions
How much did Stemtech's revenue grow year over year in Q2 2026?
Stemtech's revenue fell $69K (-10%) from $698K in Q2 2025 to $629K in Q2 2026.